Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain-of-function variants R201C and R201H
Autor: | Edward C. Cooper, Sarah Weckhuysen, Sabine Grønborg, Maurizio Taglialatela, Yong-hui Jiang, Sarah B. Mulkey, John L. Carroll, Phillip L. Pearl, Rebecca C. Spillmann, Maria Roberta Cilio, Silvia Vieker, Kristen Park, Ingrid E. Scheffer, Nishtha Joshi, David A. Koolen, Megan L. Kelly, Bruria Ben-Zeev, Joost Nicolai, Mohamad A. Mikati |
---|---|
Přispěvatelé: | Mulkey, Sarah B, Ben Zeev, Bruria, Nicolai, Joost, Carroll, John L, Grønborg, Sabine, Jiang, Yong Hui, Joshi, Nishtha, Kelly, Megan, Koolen, David A, Mikati, Mohamad A, Park, Kristen, Pearl, Phillip L, Scheffer, Ingrid E, Spillmann, Rebecca C, Taglialatela, Maurizio, Vieker, Silvia, Weckhuysen, Sarah, Cooper, Edward C, Cilio, Maria Roberta, Klinische Neurowetenschappen, MUMC+: MA Med Staf Spec Neurologie (9), RS: FHML non-thematic output |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Male Myoclonus Pediatrics Electroencephalography Epilepsy 0302 clinical medicine Registries POTASSIUM CHANNEL SUBUNITS ONSET EPILEPTIC ENCEPHALOPATHY KCNQ2 medicine.diagnostic_test Infantile spasms Epileptic encephalopathy HYPEREXCITABILITY Institutional review board Magnetic Resonance Imaging Epileptic spasms Phenotype Neurology Anesthesia Child Preschool Anticonvulsants Female medicine.symptom Spasms Infantile Rare cancers Radboud Institute for Health Sciences [Radboudumc 9] medicine.medical_specialty Encephalopathy Arginine Polymorphism Single Nucleotide Article 03 medical and health sciences VOLTAGE SENSOR medicine Humans KCNQ2 Potassium Channel Histidine Cysteine SUPPRESSION SPECTRUM Neonatal encephalopathy business.industry MUTATIONS CONVULSIONS Infant Newborn Infant Neonatal seizures medicine.disease Respiration Disorders 030104 developmental biology Respiratory failure Infantile spasm SEIZURES Neurology (clinical) Human medicine business 030217 neurology & neurosurgery Myoclonu |
Zdroj: | Epilepsia, 58, 436-445 Epilepsia Epilepsia, 58(3), 436-445. Wiley Epilepsia, 58, 3, pp. 436-445 |
ISSN: | 0013-9580 |
Popis: | Objective: To analyze whether KCNQ2 R201C and R201H variants, which show atypical gain-of-function electrophysiologic properties in vitro, have a distinct clinical presentation and outcome.Methods: Ten children with heterozygous, de novo KCNQ2 R201C or R201H variants were identified worldwide, using an institutional review board (IRB)-approved KCNQ2 patient registry and database. We reviewed medical records and, where possible, interviewed parents and treating physicians using a structured, detailed phenotype inventory focusing on the neonatal presentation and subsequent course.Results: Nine patients had encephalopathy from birth and presented with prominent startle-like myoclonus, which could be triggered by sound or touch. In seven patients, electroencephalography (EEG) was performed in the neonatal period and showed a burst-suppression pattern. However, myoclonus did not have an EEG correlate. In many patients the paroxysmal movements were misdiagnosed as seizures. Seven patients developed epileptic spasms in infancy. In all patients, EEG showed a slow background and multifocal epileptiform discharges later in life. Other prominent features included respiratory dysfunction (perinatal respiratory failure and/or chronic hypoventilation), hypomyelination, reduced brain volume, and profound developmental delay. One patient had a later onset, and sequencing indicated that a low abundance (similar to 20%) R201C variant had arisen by postzygotic mosaicism.Significance: Heterozygous KCNQ2 R201C and R201H gain-of-function variants present with profound neonatal encephalopathy in the absence of neonatal seizures. Neonates present with nonepileptic myoclonus that is often misdiagnosed and treated as seizures. Prognosis is poor. This clinical presentation is distinct from the phenotype associated with loss-of-function variants, supporting the value of in vitro functional screening. These findings suggest that gain-of-function and loss-of-function variants need different targeted therapeutic approaches. |
Databáze: | OpenAIRE |
Externí odkaz: |